GlaxoSmithKline Consumer Nigeria Plc manufactures, markets, and distributes consumer healthcare and pharmaceutical products in Nigeria. The company operates in two segments, Consumer Healthcare and Pharmaceuticals. It offers consumer healthcare products, including oral care products, over-the -counter medicines, and nutritional health care products primarily under the Panadol, Andrews Liver salt, Macleans, Sensodyne, Phensic, Lucozade, and Ribena brands; and pharmaceutical products comprising prescription drugs and vaccines principally under the Ampiclox, Amoxil and Augmentin, Zentel, and Halfan brands. The company offers its products for the treatment of asthma, malaria, depression, migraine, diabetes, heart failure, digestive conditions, and cancer. The company was formerly known as Beecham Limited. GlaxoSmithKline Consumer Nigeria Plc was incorporated in 1971 and is headquartered in Lagos, Nigeria.
glaxosmithkline consumer nig
(GLAXOSMI:Nigerian Stock Exchange)
1, Industrial Avenue
Phone: 234 1 271 1000
|Albany Molecular Research Inc||$15.85 USD||+0.35|
|AstraZeneca PLC||4,663 GBp||+3.00|
|Merck & Co Inc||$59.75 USD||+0.41|
|Sumitomo Dainippon Pharma Co Ltd||¥1,228 JPY||-22.00|
|Teva Pharmaceutical Industries Ltd||$56.81 USD||+0.23|
|View Industry Companies|
Sponsored Financial Commentaries
To contact GLAXOSMITHKLINE CONSUMER NIG, please visit www.gsk.com/ng. Company data is provided by Capital IQ. Please use this form to report any data issues.